 SAN DIEGO--BUSINESS WIRE--Quidel Corporation NASDAQ: QDEL, a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 40th Annual J.P. Morgan Healthcare Conference to be held virtually on Wednesday, January 12, 2022. Douglas Bryant, president and chief executive officer, will present that day at 1:30 p.m. Eastern time 10:30 a.m. Pacific time with a question-and-answer session scheduled immediat 